BRIEF-VEON Sells 49% Stake In TNS+ For $137.5 Million-February 2024-www.financetom.com

BRIEF-VEON Sells 49% Stake In TNS+ For $137.5 Million

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

BRIEF-VEON Sells 49% Stake In TNS+ For $137.5 Million

May 28, 2024 11:38 AM

May 28 (Reuters) - VEON Ltd:

* VEON PROGRESSES WITH ASSET-LIGHT STRATEGY, REACHES

AGREEMENT TO

SELL STAKE IN TNS+ IN KAZAKHSTAN

* VEON LTD - TOTAL CONSIDERATION FOR SALE IS USD 137.5

MILLION

* VEON SELLS 49% STAKE IN TNS+ FOR $137.5 MILLION

Source text for Eikon:

Further company coverage:

Previous page： Amphenol Insider Sold Shares Worth $12,391,938, According to a Recent SEC Filing Next page： FDA advisers vote against Lexicon Pharma's add-on drug for type 1 diabetes

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Amphenol Insider Sold Shares Worth $12,391,938, According to a Recent SEC Filing

Nov 4, 2024

04:47 PM EDT, 10/31/2024 (MT Newswires) -- David M Silverman, Senior VP, Human Resources, on Oct. 29, sold 180,000 shares in Amphenol ( APH ) for $12,391,938. Following the Form 4 filing with the SEC, Silverman has control over a total of 14,000 shares of the company, with 14,000 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/820313/000112760224026155/xslF345X05/form4.xml Price: 67.05, Change: +0.03, Percent...

FDA advisers vote against Lexicon Pharma's add-on drug for type 1 diabetes

Nov 4, 2024

Oct 31 (Reuters) - Independent advisers to the U.S. Food and Drug Administration on Thursday voted against recommending Lexicon Pharmaceuticals' ( LXRX ) add-on treatment to insulin therapy for managing blood glucose levels in adults with type 1 diabetes and chronic kidney disease. The panel voted 11 to 3 against recommending the drug, chemically known as sotagliflozin. ...

Amphenol Insider Sold Shares Worth $82,204,731, According to a Recent SEC Filing

Nov 4, 2024

04:46 PM EDT, 10/31/2024 (MT Newswires) -- Richard Adam Norwitt, Director, President & CEO, on Oct. 29, sold 1,190,000 shares in Amphenol ( APH ) for $82,204,731. Following the Form 4 filing with the SEC, Norwitt has control over a total of 2,870,652 shares of the company, with 1,938,816 shares held directly and 931,836 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/820313/000110465924113044/xslF345X05/tm2427214-1_4seq1.xml Price:...

US Steel Reports Better-Than-Expected Q3 Results, Aims To Close Nippon Steel Deal By Year End

Nov 4, 2024

United States Steel Corporation ( X ) reported its third-quarter results after Thursday's closing bell. Here's a look at the details from the report. The Details: U.S. Steel reported quarterly earnings of 56 cents per share which beat the analyst consensus estimate of 47 cents. Quarterly revenue came in at $3.85 billion, which beat the consensus estimate of $3.77 billion. U.S....